Abstract. The aim of the present study was to investigate the role of Hoxb2 and Hoxb4 gene expression induced by human cytomegalovirus (HCMV) and/or all-trans retinoic acid (ATRA) on the proliferation and committed differentiation process of human cord blood hematopoietic stem cells (HSCs) to colony-forming erythroid progenitor cells (CFU-Es) in vitro. Cord blood was collected from the fetal placenta umbilical vein in 12 cases and cultured using hematopoietic stem cell culture technique in vitro. The proliferation and differentiation of cord blood HSCs to CFU-Es were continuously disrupted with HCMV-AD169 and/or 6x10 -8 mol/l of ATRA. Expression levels of the Hoxb2 and Hoxb4 genes in the blank, ATRA, HCMV-AD169 and ATRA + HCMV treatment groups of CFU-Es were detected on day 3, 7 and 10 of culture by fluorescent quantitative reverse transcriptase-polymerase chain reaction method. Hoxb2 and Hoxb4 gene expression in each group began on day 3, obviously increased on day 7 and reached a peak on day 10. The expression levels of the Hoxb2 and Hoxb4 genes in the HCMV group were obviously down-regulated compared with the level in the blank group. However, expression levels of the Hoxb2 and Hoxb4 genes were significantly up-regulated in the HCMV + ATRA group compared with the HCMV group (P<0.05). Abnormal expression of the Hoxb2 and Hoxb4 genes induced by HCMV may play important roles in abnormal hematopoietic damage. They were also correlated with the process of erythroid hematopoiesis. ATRA (6x10 -8 mol/l) significantly up-regulated expression of the Hoxb2 and Hoxb4 genes in the normal erythroid progenitor cells and in those cells infected with HCMV as well.
Introduction
Human cytomegalovirus (HCMV) is one of the most prevalent infective factors among the population worldwide. HCMV together with toxoplasm, rubella virus, herpes simplex virus and treponema pallidum are regarded as five biological teratogenic factors. The incidence rates of HCMV infection have reached 80-90% among the Chinese (1), which is even higher among children. Numerous studies have shown that the hematopoietic system is one of the major organs suffering from HCMV infection. We found that HCMV directly damages hematopoietic progenitor cells and leads to abnormal expression of the homeobox gene (Hox) in infected cells (2) (3) (4) (5) (6) (7) (8) (9) . Recent studies have shown that the Hox gene is associated with the development of hematopoietic cells and directly affects the proliferation, differentiation and maturity of hematopoietic stem cells due to structural and functional alterations. Hoxb2 and Hoxb4 genes are considered to be the major regulatory factors in the proliferation and differentiation process of erythroid cells (10, 11) . Meanwhile, the expression of the Hox genes can be regulated by all-trans retinoic acid (ATRA). In the present study, the role of the expression of the Hoxb2 and Hoxb4 genes was assessed in the proliferation and committed differentiation process of human cord blood hematopoietic stem cells to colony-forming erythroid progenitor cells (CFUEs), and the mechanism of cord blood CFU-E damage caused by HCMV infection was evaluated at the gene level.
Materials and methods
Placental cord blood of 12 full-term infants was obtained at the Obstetrics Department, Affiliated Hosptial of Luzhou Medical College. All of the new mothers were in good health with HBSAg (-). The indices of serum anti-HCMV-IgG and HCMV-IgM of samples detected by ELISA and HCMV-DNA assessed by PCR methods were negative. HCMV-AD 169 virus strain with a titer of 10 9 pfu/l was from the Institute of Virology, Chinese Academy of Preventive Medicine. The titer used for infection was adjusted to 10 8 pfu/l by dilution with DMEM/F12 culture medium.
were isolated according to a conventional isolation method. An optimizing method applied in our department was used for the CFU-E culture. It is convenient to extract total RNA at different time points by supplementing methylcellulose in culture medium (Table I) .
Identification of erythroid progenitor cells. Benzidine was added to the culture medium on day 3, 7 and 10 for identification of the erythroid progenitor cells. The morphology, size and color of the cells were observed using an inverted microscope.
RNA extraction. Total RNA was isolated from cells in the different groups on day 3, 7 and 10 of culture using TRIzol reagent according to the manufacturer's instructions, followed by detection using 10 g/l agarose gel electrophoresis and pres- 
Real-time fluorescent quantitative-PCR. The Hoxb2 and
Hoxb4 genes were amplified using 5 µl synthesized cDNA from total RNA as a template and designed DNA sequences as primers (Table II) . PCR production was detected by agarose gel electrophoresis and preserved at -20˚C. cDNA templates were 10-fold serially diluted and served as standards with presumed original copy number (10 4 ). A sample (5 µl) from each standard was added to a 30-µl reaction system including 3 µl 10X buffer, 3 µl MgCl 2 at 25 mmol/l, 9 µl dNTP at 10 mmol/l, 1 µl dNTP at 10 mmol/l, 1 µl upstream primers at 10 µmol/l, 1 µl downstream primers at 10 µmol/l, 1 µl TaqMan probes at 10 µmol/l (Table III) , 0.3 µl Taq DNA polymerase, 14.8 µl DEPC-H 2 O and 5 µl cDNA template. The PCR reaction was performed using an FTC2000 fluorescent quantitative PCR cycler. The conditions were as follows: an initial denaturation cycle at 95˚C for 60 sec and 45 cycles at 95˚C for 10 sec, annealing at 55˚C for 30 sec, and extension at 72˚C for 1 min. The specificity of the PCR amplification was checked by a melting curve program. The copy numbers of target genes were calculated with the obtained Ct values by using standard curves.
Erythroid progenitor cells were harvested on day 3, 7 and 10 for detecting the mRNA expression of Hoxb2 and Hoxb4 genes by RQ-PCR.
Statistical analysis. Data were calculated by a comparative threshold method using SPSS version 15.0. The fold change in expression was calculated for each sample using 2 -∆∆Ct , and the values for the expression levels of Hoxb2 and Hoxb4 were represented as means ± SD. A pairwise comparison of mean values between groups (LSD method) was performed after detecting a significant difference by the Homogeneity test for variance and two-way analysis of variance. A P-value of <0.05 was considered statistically significant.
Results

RT-PCR amplification of Hoxb2, Hoxb4 and GAPDH genes.
The sizes of the amplified bands were 198, 138 and 141 bp which were consistent with the expected fragments of Hoxb2, Hoxb4 and GAPDH, respectively (Figs. 1-3 ). Tables IV  and V show that the expression levels of Hoxb2 and Hoxb4 in the ATRA group were significantly increased while they were decreased in the HCMV group compared to those of the blank group (P<0.05). There was no significant difference between the ATRA + HCMV and blank groups (P>0.05). Expression levels in the ATRA + HCMV group were significantly higher compared to those of the HCMV group (P<0.05).
Expression levels of Hoxb2 and Hoxb4. The result in
The expression levels of Hoxb2 and Hoxb4 in each group were time-dependent and continued to increase on day 3, 7 and 10. Statistical differences were noted between the two groups in terms of the protein levels (P<0.05).
The results showed that both Hoxb2 and Hoxb4 were expressed in cord blood erythroid progenitor cells and were correlated with erythroid hematopoiesis; expression of Hoxb2 and Hoxb4 was visible on day 3, significantly increased by day 7 and reached the highest level by day 10 in the process of human hemopoietic stem cell proliferation and committed differentiation to erythroid progenitor cells. HCMV may lead to abnormal hematopoietic function through the down-regulation of Hoxb2 and Hoxb4 gene expression; 6x10 -8 mol/l of ATRA up-regulated the expression of Hoxb2 and Hoxb4 in normal erythroid progenitor cells and those of cells infected by HCMV.
Discussion
HCMV infection is a common disease and a hazard to human health, particularly in children. The hematopoietic system is one of the major organs involved in HCMV infection and hematopoietic progenitor cells are the major potential sites for its occurrence. One of the mechanisms of hematopoietic suppression caused by HCMV comes from its inhibitory effect on hematopoietic progenitor cells (12) . In this study, the expression of the Hoxb2 and Hoxb4 genes was detected during the process of proliferation and differentiation of human cord blood hemopoietic stem cells to erythroid progenitor cells caused by HCMV infection. The results indicated that HCMV markedly down-regulated the expression of Hoxb2 and Hoxb4, which exerted an effect on the proliferation and differentiation of erythroid progenitor cells.
The mechanism involved in the abnormal expression of the Hox genes caused by HCMV remains unclear. Presumably, the reasons may be as follows: HCMV infection often breaks several chromosome loci in which a common locus is 17q21-22, whereas Hoxb2 and Hoxb4 are located on chromosome 17 (13) ; expression of Hox genes are regulated by ATRA, and HCMV-major immediate-early promoter (HCMV-MIEP) regulates the expression of the ATRA receptor which may influence the proliferation and differentiation of hematopoietic stem cells (14) ; HCMV-MIEP may have an effect on the expression of Hoxb genes due to expression of the HCMV gene induced by HCMV chromatin after infection (15, 16) ; the effects on HCMV infection and p38 MAPK showed a chronological feature which was also cell type-specific (17) . In addition, Thrombopoietin (TPO) may up-regulate expression of Hoxb4 via p38 MAPK (18) resulting in abnormal erythroid hematopoietic function. Therefore, expression of Hoxb2 and Hoxb4 caused by HCMV infection may be associated with the MAPK signal transduction pathway.
Hoxb2 was only detected at the late stage of differentiation of erythroid cells. Hoxb2 expression is regulated by GATA-1 and interacts with the control region of the γ-globulin gene (10). Díaz et al (19) found that p160 is a novel regulator of Prep1-Pbx1 transcriptional activity and inhibits Prep1-dependent Hoxb2 expression in retinoic acid-treated NT2-D1 cells. Regulation of the differentiation of hematopoietic stem cells via the inhibition of Hoxb2 expression by p160 warrants further study. In addition, another study showed that ATRA up-regulated Hoxb6 expression (20) which was consistent with our findings. Hoxb4 protein activity was found to sustain a rather high level at the early stage of mature erythroid cells and granulopoietic cells which directly influenced the proliferation of progenitor cells at the late stage (11) and accelerated the differentiation of hematopoietic stem cells (21, 22) . Hoxb4 was found to up-regulate transcription factor AP-1 and its subunits Jun-B and ra-1 that allow for the up-regulation of the expression of cyclin D1, reduction in the cell cycle and acceleration of hemopoiesis (23) . Nuclear factor Y, thrombopoietin and AP-1 complex may participate in the transcription of Hoxb4 (24) . Nuclear factor Y and thrombopoietin were found to up-regulate the expression of Hoxb4 via the PKA and p38 MAPK signaling pathway, respectively (25) . In the present study, the Hoxb2 and Hoxb4 genes were expressed in cord blood erythroid progenitor cells in vitro, which suggests that there is a correlation between Hoxb2 and Hoxb4 genes and erythroid hematopoiesis.
ATRA induces proliferation and differentiation in a variety of cells (26) . ATRA (8-10 mol/l) promotes the proliferation and reduces apoptosis of hematopoietic stem cells. In the present study, the result showed that ATRA up-regulated the expression of Hoxb2 in the process of hematopoietic stem cell proliferation and committed differentiation to erythroid progenitor cells compared to the blank group induced by 6x10 -8 mol/l of ATRA. ATRA was found to induce expression of the Hox genes mainly depending on its retinoic acid receptor (RAR) and the retinene receptor that are present in cell nuclei. ATRA and the nuclear receptor in a dimeric form directly integrates with the ATRA-specific response element, which causes activation or inhibition of gene transcription (27) . Studies have indicated that ATRA induces the expression of the Hox genes. Genes in the 3' region of Hox are the earliest to be activated and have a high sensitivity to ATRA, while the result is actually the pposite for those in the 5' region. Allelic mutation of Hox genes is positively correlated with the phenotype, and the degree of mutation is associated with the number of interference factors. For instance, ATRA at a low concentration can promote hematopoietic stem cell differentiation to erythroid cells while it can inhibit this process at a high concentration. ATRA was found to stimulate the differentiation of granulopoietic cells to terminal cells and influenced the differentiation of hematopoietic stem cells during the embryonic period of mammals (28) . ATRA (1 µmol/l) was found to inhibit proliferation and differentiation of human hematopoietic stem cells in vitro (29) . The inhibition rate of human leukemia cell strains such as HL-60 was 50% as induced by 3x10 -10 to 10 -9 mmol/l of ATRA while the proliferation rate was increased to 150% after treatment with 3x10 -9 to 10 -8 mmol/l of ATRA. In the present study, 6x10 -8 mol/l of ATRA was utilized based on previous cell toxicity experiments as well as pertinent literature. The results showed that ATRA at this concentration up-regulates expression of the Hoxb4 gene in normal hema-topoietic progenitor cells. Additional studies are underway to determine the relationship between the concentration of ATRA and the expression of the Hox6 gene and how to influence the proliferation and differentiation of hematopoietic cells through the change in the ATRA concentration.
In addition, main immediate early antigens (IEA) were found to increase the enhancer acitivity of interleukin 6 (1, 30) and ATRA was found to inhibit interleukin 6 via its receptors (31) . Thus, it is presumable that the inhibitory effect of ATRA on interleukin 6 via ATRA receptors may relieve HCMV infection to some degree.
In the present study, our experiments were only confined to in vitro hematopoietic inhibition caused by HCMV infection and the effect of HCMV/ATRA on the expression of the Hoxb2 and Hoxb4 genes. Thus, further studies are required to evaluate how HCMV inhibits hematopoiesis, how HCMV/ATRA regulates the expression of the Hoxb2 and Hoxb4 genes in vivo and how they cause damage to the hematopoietic system.
